World-first Centre for Psychedelics Research launched in UK

[Elderberry]

New Atlas by Rich Haridy 4/28/2019

In an incredible milestone, representing the ongoing legitimization of psychedelic science, a formal facility dedicated to the study of psychedelics has been launched at Imperial College London. While the newly established Centre for Psychedelics Research is not the only major psychedelic research group in the world, it is the first to be officially integrated into a large academic institution.

The Centre will be led by Robin Carhart-Harris, a leading UK figure in the new wave of psychedelic research. Carhart-Harris has worked for well over a decade in the field of psychopharmacology, and is known for completing the first modern brain imaging study of the effects of LSD.

"This new Centre represents a watershed moment for psychedelic science; symbolic of its now mainstream recognition," says Carhart-Harris. "Psychedelics are set to have a major impact on neuroscience and psychiatry in the coming years. It's such a privilege to be at the forefront of one of the most exciting areas in medical science. I am immensely grateful to the donors who have made all of this possible."

More: https://newatlas.com/centre-psychedelic-research-imperial-college-london/59455/

[Elderberry]

FDA Recognizes Psilocybin As 'Breakthrough Therapy' for Depression

The designation could be a prelude to approving the forbidden psychedelic drug as a medicine.

reason.com Jacob Sullum | 10.25.2018

https://reason.com/2018/10/25/fda-recognizes-psilocybin-as-breakthroug/

The only reference to psilocybin on the Food and Drug Administration's website appears in the agency's Bad Bug Book: Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins, where the psychedelic compound is described as a "neurotoxin" found in mushrooms. But according to the FDA, psilocybin is also a "breakthrough therapy" for major depression.

That designation, which the company seeking approval of psilocybin as a medicine announced this week, means "preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies." Based on that evidence, the FDA agrees to "expedite the development and review of such drug."

The FDA's dueling portrayals of psilocybin as a scary fungal neurotoxin and a promising treatment for depression are part of a broader story about forbidden drugs, including MDMA, marijuana, and LSD, whose benefits scientists are once again studying with government approval after decades of neglect. The rehabilitation of these substances, which may ultimately make them available as prescription drugs, is a far cry from the pharmacological freedom that libertarians favor. But it represents a welcome return to empiricism in an area of public policy long driven by irrational prejudice.

More at link.

[truth_seeker]

George Hunter White, uncle of a friend of mine.

https://en.wikipedia.org/wiki/Operation_Midnight_Climax

[Elderberry]

George Hunter White, uncle of a friend of mine.

https://en.wikipedia.org/wiki/Operation_Midnight_Climax

A good friend I hope. I hope he turned you on to some righteous stuff. Any orange barrels, orange sunshine, blotter, or heavenly blues?